Requirement for Rac1 in a K-ras-induced lung cancer in the mouse

被引:124
作者
Kissil, Joseph L. [1 ]
Walmsley, Marita J.
Hanlon, Linda
Haigis, Kevin M.
Kim, Carla F. Bender
Sweet-Cordero, Alejandro
Eckman, Matthew S.
Tuveson, David A.
Capobianco, Anthony J.
Tybulewicz, Victor L. J.
Jacks, Tyler
机构
[1] Wistar Inst Anat & Biol, Mol & Cellular Ongenes Program, Philadelphia, PA 19104 USA
[2] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA
[3] Natl Inst Med Res, Div Cell Biol & Immune, London, England
[4] MIT, Dept Biol, Cambridge, MA USA
[5] MIT, Howard Hughes Med Inst, Cambridge, MA USA
[6] Stanford Univ, Sch Med, Dept Pediat, Div Canc Biol, Stanford, CA USA
[7] Univ Cambridge, Cambridge Res Inst, Canc Res UK, Dept Oncol, Cambridge, England
基金
英国医学研究理事会;
关键词
D O I
10.1158/0008-5472.CAN-07-2300
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Given the prevalence of Ras mutations in human cancer, it is critical to understand the effector pathways downstream of oncogenic Ras leading to transformation. To directly assess the requirement for Rac1 in K-ras-induced tumorigenesis, we employed a model of lung cancer in which an oncogenic allele of K-ras could be activated by Cre-mediated recombination in the presence or absence of conditional deletion of Rac1. We show that Rac1 function is required for tumorigenesis in this model. Furthermore, although Rac1 deletion alone was compatible with cell viability and proliferation, when combined with K-ras activation in primary epithelial cells, loss of Rac1 caused a profound reduction in proliferation. These data show a specific requirement for Rac1 function in cells expressing oncogenic K-ras.
引用
收藏
页码:8089 / 8094
页数:6
相关论文
共 29 条
  • [1] Bax and Bak independently promote cytochrome c release from mitochondria
    Degenhardt, K
    Sundararajan, R
    Lindsten, T
    Thompson, C
    White, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) : 14127 - 14134
  • [2] Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO
  • [3] 2-B
  • [4] Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins
    Frost, JA
    Steen, H
    Shapiro, P
    Lewis, T
    Ahn, N
    Shaw, PE
    Cobb, MH
    [J]. EMBO JOURNAL, 1997, 16 (21) : 6426 - 6438
  • [5] Hinz M, 1999, MOL CELL BIOL, V19, P2690
  • [6] Hyperactivation of p21ras and the hematopoietic-specific Rho GTPase Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro
    Ingram, DA
    Hiatt, K
    King, AJ
    Fisher, L
    Shivakumar, R
    Derstine, C
    Wenning, MJ
    Diaz, B
    Travers, JB
    Hood, A
    Marshall, M
    Williams, DA
    Clapp, DW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (01) : 57 - 69
  • [7] Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
    Jackson, EL
    Willis, N
    Mercer, K
    Bronson, RT
    Crowley, D
    Montoya, R
    Jacks, T
    Tuveson, DA
    [J]. GENES & DEVELOPMENT, 2001, 15 (24) : 3243 - 3248
  • [8] Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
    Johnson, L
    Mercer, K
    Greenbaum, D
    Bronson, RT
    Crowley, D
    Tuveson, DA
    Jacks, T
    [J]. NATURE, 2001, 410 (6832) : 1111 - 1116
  • [9] Joneson T, 1999, MOL CELL BIOL, V19, P5892
  • [10] Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors
    Jordan, P
    Brazao, R
    Boavida, MG
    Gespach, C
    Chastre, E
    [J]. ONCOGENE, 1999, 18 (48) : 6835 - 6839